5 -Amino-1MQ is an investigational compound that acts as a selective inhibitor of the NNMT enzyme. By blocking this enzyme, it prevents age-related metabolic slowdown, restores NAD⁺ levels, and promotes fat oxidation. It is not currently approved for human use, and its long-term safety remains unknown. [1, 2, 3, 4, 5] 5 -Amino-1MQ
Mechanism of action
-
- NNMT Inhibition: Nicotinamide N-methyltransferase (NNMT) is an enzyme often overexpressed in adipose tissue. It scavenges SAM (S-adenosylmethionine) and consumes nicotinamide. By inhibiting NNMT, 5-Amino-1MQ preserves cellular reserves of NAD⁺ and SAM. [1, 2, 3, 4, 5]
- Weight loss: Animal studies indicate that increased NAD⁺ reactivates mitochondrial function, directing adipose tissue towards fat burning rather than storage. [1, 2, 3]
- Anti-aging potential: By stimulating NAD⁺, the compound activates sirtuins, proteins involved in cell repair and fighting inflammation. [1]
Regulatory status
Although studied in laboratories using body regeneration protocols, this peptide, or “small molecule,” has not received FDA approval for therapeutic use in humans. Evidence of its efficacy and tolerability comes primarily from preclinical research on animal models, although some suppliers offer it in capsule form. [1, 2, 3, 4, 5, 6]
To learn more about the basic research, you can consult the detailed presentation of how the molecule works on the Peptide Genesis blog. The metabolic mechanisms and potential side effect profiles are also summarized in the MediSearch research article .
To help you move forward with your research, tell me:
- Are you interested in this molecule for weight loss or for its anti-aging/energy potential ?
- Would you like us to discuss the differences between 5-Amino-1MQ and other metabolic treatments (such as GLP-1 analogues)?
Reviews
There are no reviews yet.